Market closed

IO Biotech/IOBT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About IO Biotech

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Ticker

IOBT
Trading on

Industry

Biotechnology

Headquarters

Copenhagen, Denmark

Employees

74

IO Biotech Metrics

BasicAdvanced
$67M
Market cap
-
P/E ratio
-$1.42
EPS
0.48
Beta
-
Dividend rate
$67M
0.48
$2.10
$0.73
741K
7.845
7.341
1.529
2.233
-50.98%
-87.66%
0.69
0.69
-0.775
-44.78%
-83.27%

What the Analysts think about IO Biotech

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for IO Biotech stock.

IO Biotech Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

IO Biotech Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy IOBT

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for IO Biotech stock?

IO Biotech (IOBT) has a market cap of $67M as of October 05, 2024.

What is the P/E ratio for IO Biotech stock?

The price to earnings (P/E) ratio for IO Biotech (IOBT) stock is 0 as of October 05, 2024.

Does IO Biotech stock pay dividends?

No, IO Biotech (IOBT) stock does not pay dividends to its shareholders as of October 05, 2024.

When is the next IO Biotech dividend payment date?

IO Biotech (IOBT) stock does not pay dividends to its shareholders.

What is the beta indicator for IO Biotech?

IO Biotech (IOBT) has a beta rating of 0.48. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.